Most Recent
ObjectiVision has presented a "limited" and "debatable" case that its source code for a glaucoma testing device was copied, the Federal Court heard Thursday as the trial in a four-year spat with the University of Sydney over IP rights came to a close.
Ophthalmic diagnostic device manufacturer ObjectiVision has made its final pitch to the Federal Court at the end of trial in a long-running intellectual property and contract dispute with the University of Sydney, saying in closing submissions that the school had run a "curious" case.
Westpac will pay $35 million to settle a case brought by ASIC alleging the bank breached responsible lending laws through its automated home loan system, the largest civil penalty ever awarded under the National Credit Act.
A judge has ruled in-house counsel at Glencore can't view "highly confidential" documents related to the possible sale by Cargill of its Joe White malt business.
Viterra is blaming several former employees for representations made about malt quality in the lead-up to the $420 million sale of its Joe White business to Cargill Australia in 2013.
The ACCC will decide by November 8 whether the proposed merger of Nine Entertainment with Fairfax Media raises competition concerns.
Australian luxury watch retailer Watches of Switzerland has lost a bid to strike out Transport for NSW's defences in a case seeking damages for the ongoing construction of the light rail project in Sydney's CBD.
A claim for damages by Optus over Telstra's 'Unlimited' ad campaign, which was found to be misleading and deceptive, appears to have been resolved by the rivals out of court.
Ophthalmic diagnostic device manufacture ObjectiVision can't file amended claims for damages following a trial in a copyright and contract case against the University of Sydney, with a judge saying the school would be "severely prejudiced" if the new claims were allowed.
Cargill has won court approval to amend its pleading against Viterra to include details of a law firm meeting in which Viterra executives allegedly made assurances that there were no quality issues with its malt, more than two months into the trial over the $420 million sale of Viterra's Joe White Maltings business to Cargill in 2013.